Inventor · disambiguated record
Corey M. Reeves
Also filed as: REEVES COREY · REEVES COREY M
15 granted patents·6 pending applications·21 citations·filing 2016–2025
88Inventor score
Top patents by PatentIndex Score
21 records- 0196US12378239B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0296US12378237B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0396US12378236B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0496US12378238B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2025·Granted Aug 5, 2025·1 cites·20 claims
- 0596US12024507B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2022·Granted Jul 2, 2024·14 cites·32 claims
- 0693US11845770B2Ascaroside derivatives and methods of useCALIFORNIA INST OF TECHN·Filed 2022·Granted Dec 19, 2023·2 cites·21 claims
- 0789US12410163B2Compounds as GLP-IR agonistsTERNS PHARMACEUTICALS INC·Filed 2023·Granted Sep 9, 2025·1 cites·23 claims
- 0886US2025282772A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0980US2023150998A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1077US12486261B2Compounds as GLP-1R agonistsTERNS PHARMACEUTICALS INC·Filed 2024·Granted Dec 2, 2025·0 cites·46 claims
- 1168US12473323B2Ascaroside derivatives and methods of useCALIFORNIA INST OF TECHN·Filed 2020·Granted Nov 18, 2025·0 cites·23 claims
- 1263US2023322744A1Compounds as glp-1r agonistsTERNS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1356US2024059682A1Thyroid hormone receptor beta agonist compoundsTERNS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1452US12473289B2Heterocyclic compounds as delta-5 desaturase inhibitors and methods of useAMGEN INC·Filed 2020·Granted Nov 18, 2025·0 cites·10 claims
- 1548US10889581B2Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jan 12, 2021·0 cites·21 claims
- 1647US12428416B2ERK inhibitors and uses thereofCALIFORNIA INST OF TECHN·Filed 2019·Granted Sep 30, 2025·0 cites·20 claims
- 1746US10947223B2Substituted oxazines as beta-secretase inhibitorsAMGEN INC·Filed 2017·Granted Mar 16, 2021·0 cites·26 claims
- 1846US2023116602A1Mcl1 inhibitors and uses thereofCALIFORNIA INST OF TECHN·Filed 2020·Application pending·0 cites
- 1945US11021493B21,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jun 1, 2021·0 cites·33 claims
- 2044US2022227738A1Kras g12c inhibitors and uses thereofCALIFORNIA INST OF TECHN·Filed 2020·Application pending·0 cites
- 2138US10246429B2Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Granted Apr 2, 2019·0 cites·54 claims
Join the waitlist — get patent alerts
Get an alert when Corey M. Reeves files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →